PeptiDream - Public Comps and Valuation Multiples

PeptiDream Overview

About PeptiDream

PeptiDream Inc is a biopharmaceutical company, engaged in the research and development of new pharmaceutical candidates. It discovers constrained peptides, small molecules, and peptide-drug conjugate therapeutics using its Peptide Discovery Platform System. The company aspires to be a leader in drug discovery and development to address unmet medical needs and improve the quality of life of patients worldwide.

Founded

2006

HQ

Employees

Website

peptidream.com

Sectors

Drug Development & Therapeutics
BioTech

Financials

LTM Revenue $305M

LTM EBITDA $141M

EV

$1.3B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

PeptiDream Financials

As of September 2025, PeptiDream reported last 12-month revenue of $305M and EBITDA of $141M.

In the same period, PeptiDream generated $223M in LTM gross profit and $104M in net income.

See PeptiDream valuation multiples based on analyst estimates

PeptiDream P&L

In the most recent fiscal year, PeptiDream reported revenue of $306M and EBITDA of $156M.

PeptiDream expects next 12-month revenue of XXX and NTM EBITDA of XXX

See PeptiDream valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$305M	XXX	$306M	XXX	XXX	XXX
Gross Profit	$223M	XXX	$226M	XXX	XXX	XXX
Gross Margin	73%	XXX	74%	XXX	XXX	XXX
EBITDA	$141M	XXX	$156M	XXX	XXX	XXX
EBITDA Margin	46%	XXX	51%	XXX	XXX	XXX
EBIT	$134M	XXX	$139M	XXX	XXX	XXX
EBIT Margin	44%	XXX	45%	XXX	XXX	XXX
Net Profit	$104M	XXX	$98.5M	XXX	XXX	XXX
Net Margin	34%	XXX	32%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for PeptiDream including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $305M. EBITDA for the last twelve months was $141M. In the most recent fiscal year, PeptiDream achieved $306M in revenue and $156M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$305M	Analyst estimates available to subscribers	$306M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$223M	Analyst estimates available to subscribers	$226M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	72.9% gross margin	Analyst estimates available to subscribers	73.9% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$141M	Analyst estimates available to subscribers	$156M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	46.2% EBITDA margin	Analyst estimates available to subscribers	51.0% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$134M	Analyst estimates available to subscribers	$139M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	43.9% EBIT margin	Analyst estimates available to subscribers	45.2% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$104M	Analyst estimates available to subscribers	$98.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	34.1% net profit margin	Analyst estimates available to subscribers	32.2% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for PeptiDream

This financial data table provides comprehensive performance metrics for PeptiDream, a company based in Japan. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

PeptiDream generated $305M in revenue over the last twelve months.
The company achieved $141M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $223M.
Net income over the last twelve months reached $104M.

Fiscal Year Performance

In the most recent fiscal year, PeptiDream reported $306M in total revenue.
Fiscal year EBITDA was $156M.
The company maintained a gross profit margin of 73.9% in the most recent fiscal year.
EBITDA margin for the fiscal year was 51.0%.
Net profit margin reached 32.2% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for PeptiDream. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

PeptiDream Stock Performance

PeptiDream has current market cap of JPY 209B (or $1.4B), and EV of JPY 194B (or $1.3B).

Market Cap Evolution

PeptiDream Stock Data

As of October 17, 2025, PeptiDream's stock price is JPY 1617 (or $11).

See PeptiDream trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$1.3B	$1.4B	XXX	XXX	XXX	XXX	$0.72

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

PeptiDream Valuation Multiples

PeptiDream's trades at 4.2x EV/Revenue multiple, and 8.2x EV/EBITDA.

See valuation multiples for PeptiDream and 15K+ public comps

PeptiDream Financial Valuation Multiples

As of October 17, 2025, PeptiDream has market cap of $1.4B and EV of $1.3B.

Equity research analysts estimate PeptiDream's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

PeptiDream has a P/E ratio of 13.2x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$1.4B	XXX	$1.4B	XXX	XXX	XXX
EV (current)	$1.3B	XXX	$1.3B	XXX	XXX	XXX
EV/Revenue	4.2x	XXX	4.2x	XXX	XXX	XXX
EV/EBITDA	9.0x	XXX	8.2x	XXX	XXX	XXX
EV/EBIT	9.5x	XXX	9.2x	XXX	XXX	XXX
EV/Gross Profit	5.7x	XXX	n/a	XXX	XXX	XXX
P/E	13.2x	XXX	13.9x	XXX	XXX	XXX
EV/FCF	13.3x	XXX	9.0x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get PeptiDream Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

PeptiDream Margins & Growth Rates

PeptiDream's last 12 month revenue growth is -1%

PeptiDream's revenue per employee in the last FY averaged $3.7M, while opex per employee averaged $1.1M for the same period.

PeptiDream's rule of 40 is 30% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

PeptiDream's rule of X is 43% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for PeptiDream and other 15K+ public comps

PeptiDream Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	-1%	XXX	-1%	XXX	XXX	XXX
EBITDA Margin	46%	XXX	51%	XXX	XXX	XXX
EBITDA Growth	-10%	XXX	53%	XXX	XXX	XXX
Rule of 40	30%	XXX	50%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	43%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$3.7M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$1.1M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	9%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	29%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial